Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Barranco

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Investigational New Drugs|January 1, 1983
Heterogeneous responses of an in vitro model of human stomach cancer to anticancer drugsS C Barranco, C M Townsend, M A Quraishi, et al.
Cancer Research|July 1, 1982
Enhanced cell killing through the use of cell kinetics-directed treatment schedules for two-drug combinations in vitroS C Barranco, J T May, W Boerwinkle, et al.
Cancer Research|October 15, 1994
Intratumor variability in prognostic indicators may be the cause of conflicting estimates of patient survival and response to therapyS C Barranco, R R Perry, M E Durm, et al.
Cancer Research|July 1, 1982
Use of 1,2:5,6-dianhydrogalactitol in studies on cell kinetics-directed chemotherapy schedules in human tumors in vivoS C Barranco, C M Townsend, J J Costanzi, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Investigational New Drugs|January 1, 1983
Heterogeneous responses of an in vitro model of human stomach cancer to anticancer drugsS C Barranco, C M Townsend, M A Quraishi, et al.
Cancer Research|July 1, 1982
Enhanced cell killing through the use of cell kinetics-directed treatment schedules for two-drug combinations in vitroS C Barranco, J T May, W Boerwinkle, et al.
Cancer Research|October 15, 1994
Intratumor variability in prognostic indicators may be the cause of conflicting estimates of patient survival and response to therapyS C Barranco, R R Perry, M E Durm, et al.
Cancer Research|July 1, 1982
Use of 1,2:5,6-dianhydrogalactitol in studies on cell kinetics-directed chemotherapy schedules in human tumors in vivoS C Barranco, C M Townsend, J J Costanzi, et al.
Pageof 8